- Antibody titer after COVID-19 vaccination in liver transplant recipients
-
Mita A, Shimizu A, Ohno Y, Kubota K, Masuda Y, Notake T, Yoshizawa K, Soejima Y
- KMID: 2535620
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S104.
- doi: 10.4285/ATW2022.F-2222
Background: COVID-19 has raised a pandemic. A mRNA-based vaccine is released for prophylaxis, and its high efficacy has been reported. However, there is a paucity of data in immunosuppressed individuals.... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term catch-up growth and risk factors for short adult height after pediatric liver transplantation
-
Umemura K, Mita A, Ohno Y, Masuda Y, Yoshizawa K, Kubota K, Notake T, Shimizu A, Soejima Y
- KMID: 2535624
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S108.
- doi: 10.4285/ATW2022.F-2278
Background: Children who require liver transplantation (LTx) for end-stage liver disease generally have severe growth retardation. After LTx, recipients experience catch-up growth (CUG), though there are not a few cases... -
- CITED
-
- Close
- SHARE
-
- Close
- Conceptual changes in small-for-size graft and small-for-size syndrome in living donor liver transplantation
-
Ikegami T, Kim JM, Jung DH, Soejima Y, Kim DS, Joh JW, Lee SG, Yoshizumi , Mori M
- KMID: 2468156
- Korean J Transplant.
- 2019 Dec;33(4):65-73.
- doi: 10.4285/jkstn.2019.33.4.65
Early series in living donor liver transplantation (LDLT) in adults demonstrated a lower safe limit of graft volume standard liver volume ratio 25%–45%. A subsequent worldwide large LDLT series proposed... -
- CITED
-
- Close
- SHARE
-
- Close
